Clinical Trial Update: Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating recombinant human superoxide dismutase (rhSOD) and vascular reactivity in inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Drugs mentioned

• Recombinant Human Superoxide Dismutase (recombinant human superoxide dismutase)

Snippet

Sponsor: Medical University of Vienna | Conditions: Inflammation | Phase 1 | Status: COMPLETED